Preeclampsia Diagnostics Market Outlook:
Preeclampsia Diagnostics Market size was valued at USD 2.27 Billion in 2025 and is expected to reach USD 6 Billion by 2035, registering around 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of preeclampsia diagnostics is evaluated at USD 2.48 Billion.
The growth of this market can be propelled by the increasing prevalence of preterm births. In least-developed countries such as Bangladesh, Afghanistan and Central Africa, infections, malaria, and high teenage pregnancy rates are the main causes of premature births. As per a report of World Health Organization, 14 million births were pre-termed in 2020 with 1 million of death out of complications.
The main trend of the market is being recognized as an increasing need for companion diagnostics. With the growing need for an understanding of patient needs and the provision of personalized medicinal products, there is increasing demand for companion diagnostics. This trend will be more widespread and is expected to allow the entry of POC products including laboratory tests for preeclampsia into new markets. This further leads to disease management, patient satisfaction, and treatment adherence. All these, factors are expected to boost the market growth of preeclampsia diagnostics in the estimated period.
